Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP286928.RANDZjB7MqBqpyaKRxzTDvX75ySEb2k5qdZHJ9jL9-G1g130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP286928.RANDZjB7MqBqpyaKRxzTDvX75ySEb2k5qdZHJ9jL9-G1g130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP286928.RANDZjB7MqBqpyaKRxzTDvX75ySEb2k5qdZHJ9jL9-G1g130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP286928.RANDZjB7MqBqpyaKRxzTDvX75ySEb2k5qdZHJ9jL9-G1g130_provenance.
- NP286928.RANDZjB7MqBqpyaKRxzTDvX75ySEb2k5qdZHJ9jL9-G1g130_assertion description "[Somatic TET2 mutations are frequently observed in myelodysplastic syndromes (MDS), myeloproliferative neoplasms (MPN), MDS/MPN overlap syndromes including chronic myelomonocytic leukaemia (CMML), acute myeloid leukaemias (AML) and secondary AML (sAML).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP286928.RANDZjB7MqBqpyaKRxzTDvX75ySEb2k5qdZHJ9jL9-G1g130_provenance.
- NP286928.RANDZjB7MqBqpyaKRxzTDvX75ySEb2k5qdZHJ9jL9-G1g130_assertion evidence source_evidence_literature NP286928.RANDZjB7MqBqpyaKRxzTDvX75ySEb2k5qdZHJ9jL9-G1g130_provenance.
- NP286928.RANDZjB7MqBqpyaKRxzTDvX75ySEb2k5qdZHJ9jL9-G1g130_assertion SIO_000772 21057493 NP286928.RANDZjB7MqBqpyaKRxzTDvX75ySEb2k5qdZHJ9jL9-G1g130_provenance.
- NP286928.RANDZjB7MqBqpyaKRxzTDvX75ySEb2k5qdZHJ9jL9-G1g130_assertion wasDerivedFrom befree-20140225 NP286928.RANDZjB7MqBqpyaKRxzTDvX75ySEb2k5qdZHJ9jL9-G1g130_provenance.
- NP286928.RANDZjB7MqBqpyaKRxzTDvX75ySEb2k5qdZHJ9jL9-G1g130_assertion wasGeneratedBy ECO_0000203 NP286928.RANDZjB7MqBqpyaKRxzTDvX75ySEb2k5qdZHJ9jL9-G1g130_provenance.
- befree-20140225 importedOn "2014-02-25" NP286928.RANDZjB7MqBqpyaKRxzTDvX75ySEb2k5qdZHJ9jL9-G1g130_provenance.